Latest News

Kratom Industry to Congress: Protect Safe, Natural Botanical Products and Consumer Choice in Pending Drug Legislation

WASHINGTON–(BUSINESS WIRE)–#Kratom–The Kratom Trade Association (KTA) urges Congress to reconcile the Opioid Crisis Response Act of 2018 (OCRA, S. 2680) with the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT, H.R. 6) while resisting demands to add language from the “Stop the Importation and Trafficking of Synthetic Analogues” (SITSA) Act H.R. 2851, which could restrict access to natural botanical products such as Kratom, which millions of American consumers be

Source link

Related posts

Scientists unravel how bacterial persister cells manipulate our immune cells


New European HTN Guidelines Hit Hard With Initial Therapy, Keep ‘High-Normal’ Label


Breast Cancer Treatment Adherence Varies by Race


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World